)
Masimo (MASI) investor relations material
Masimo 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business performance and financial highlights
Achieved over $1.5 billion in revenue, 9%+ annual growth, and 11%+ quarterly growth in Q4, with 500 basis points margin expansion and 30%+ EPS growth in the past year.
80%+ recurring revenue and 99%+ renewal rate, with a resilient supply chain and strong engineering retention.
Guidance met or exceeded for revenue and earnings, expecting to close the year at the high end of guidance.
Long-range plan targets 7%-10% annual growth and 30% operating margin by 2028, with EPS approaching $8.
Strong cash flow and share buybacks, with natural leverage expected to drive future profitability.
Strategic focus and growth drivers
Growth strategy centers on U.S. pulse oximetry (40% of growth), international expansion (20%), advanced monitoring (one-third), and new product launches.
U.S. pulse ox market share at 55%, growing 1-2 points per year; international share at 35% in a faster-growing $800M market.
Advanced monitoring market share at 10%-15%, with double-digit growth potential.
Continuous monitoring seen as a $2B market opportunity, pending regulatory and technological advances.
Focused on commercial excellence, innovation, and expanding in Japan and Asia-Pacific, where significant growth potential exists.
Innovation, product pipeline, and AI integration
New product launches planned in every major category, including next-gen monitors and wearables.
AI and algorithm development are core strengths, with a dedicated team and a pipeline including AFib detection, opioid-induced respiratory depression, and predictive analytics.
Radius VSM, a wearable vital signs monitor, moving from pilot to full launch; next-gen Root monitors to launch by end of 2027.
Smart sensors for opioid-induced respiratory depression and AFib detection submitted to FDA, with launches expected in 2026.
Wearable strategy being developed for continuous hospital monitoring, with multiple FDA-cleared devices already in portfolio.
Next Masimo earnings date
Next Masimo earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)